Albayram O, Herbert MK, Kondo A, Tsai CY, Baxley S, et al
recently developed a novel compound, 33c, which inhibited the upregulated protein expression of the ASK1-p38/JNK signaling pathway in TNF--treated HGC-27 cells and alleviated lipid accumulation in LO2 cells [117]
With few exceptions, recent meta-analyses report that GLP-1 receptor therapies do not increase cancer incidence and may lower risk in some cases
It has been shown along with the triglyceride tributyrin to regulate cytokine levels, eliciting strong anti-inflammatory effects
A practical periconception management approach is as follows: (i) Target achievement: Continue treatment alongside lifestyle intervention until pre-specified weight and metabolic targets are met (e.g., 5%10% weight loss with improvement in IR markers)
In this article: 1/ How do weight-loss medications work